TheraRadar
Clinical-Stage Companies / IlDong Pharmaceutical

IlDong Pharmaceutical

Pre-Approval PRO BETA
🟡

Slowing Activity

No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 11/13/2024

26
Total Trials
7
Phase 3
1
Phase 2
1
Recruiting
164
Score

Pipeline by Phase

Phase 3
7
Phase 2
1
Phase 1
17

Therapeutic Focus

Healthy Healthy Adult Subjects Chronic Hepatitis B Acute Coronary Syndrome Hypertension

Clinical Trials (26)

NCT02792088 Phase 3 COMPLETED

Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside Analogues

Started: 7/1/2015

NCT04218162 Phase 3 COMPLETED

Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean

Started: 3/24/2020

NCT02262143 Phase 3 COMPLETED

Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia

Started: 11/1/2014

NCT03566316 Phase 3 COMPLETED

Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia

Started: 11/24/2015

NCT02749994 Phase 3 COMPLETED

A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)

Started: 4/1/2016

NCT02145104 Phase 3 COMPLETED

Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With Hypertension

Started: 6/17/2014

NCT02738632 Phase 3 COMPLETED

Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients

Started: 5/1/2015

NCT03363269 Phase 2 COMPLETED

Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease

Started: 4/12/2016

NCT06635226 Phase 1 RECRUITING

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult Subjects

Started: 11/13/2024

NCT06063291 Phase 1 COMPLETED

Single Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult Subjects

Started: 11/20/2023

NCT05604287 Phase 1 TERMINATED

Safety, Tolerability, and Pharmacokinetics of ID119031166M With the Exploration of Pharmacodynamic Effects

Started: 10/10/2022

NCT03889145 Phase 1 COMPLETED

A Study to Evaluate the Drug-drug Interaction Between Telmisartan, Amlodipine and Hydrochlorothiazide

Started: 12/19/2013

NCT02419820 Phase 1 TERMINATED

Dose-escalation, Repeated and Single Oral Dosing Study

Started: 3/1/2015

NCT02034292 Phase 1 TERMINATED

Safety Study of APD-791 With Aspirin and/or Clopidogrel

Started: 2/1/2014

NCT03032315 Phase 1 COMPLETED

Compare the Pharmacokinetics of TAH(80/10/12.5) Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers

Started: 10/1/2016

NCT02739672 Phase 1 COMPLETED

Clinical Trial to Compare the Pharmacokinetics of TAH Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers

Started: 1/2/2016

NCT02300688 Phase 1 COMPLETED

Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult Volunteers

Started: 12/1/2014

NCT02343250 Phase 1 COMPLETED

A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and Valsartan

Started: 3/1/2015

NCT02103647 Phase 1 COMPLETED

Clinical Trial to Compare The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg and Immediate Release Formulation

Started: 5/1/2013

NCT02103686 Phase 1 COMPLETED

Study for Comparing The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg With Immediate Release Formulation and to Assess the Effect of High Fat Diet in Healthy Male Subjects

Started: 11/1/2012

NCT02106130 Phase 1 COMPLETED

A Drug Interaction Study of Mosapride and Rebamipide

Started: 5/1/2013

NCT02088918 Phase 1 COMPLETED

A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male Subjects

Started: 10/1/2012

NCT01904318 Phase 1 COMPLETED

A Phase I Study of IDP-73152 Mesylate in Health Male Volunteer

Started: 7/1/2013

NCT01838967 Phase 1 COMPLETED

A Drug Interaction Study of Cilnidipine and Valsartan

Started: 4/1/2013

NCT01880502 Phase 1 COMPLETED

Pharmacokinetic Study of Belviq in Adult Korean Volunteers

Started: 6/1/2013

NCT03885778 Phase 4 COMPLETED

A Food Effect Study of Besifovir in Healthy Subjects

Started: 1/13/2019

Drug Candidates

ID110521156 Placebo of 110521156 Placebo of ID110521156 ID119031166M Placebo Besifovir 150mg Tenofovir 300mg Lasmiditan 50mg Lasmiditan 100mg ID1201
Activity Status: Slowing
Last Trial Started: 11/13/2024
Last Trial Ended: 7/11/2024
Trials (12 months): 0
Completed Trials: 22
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.